COM:VOYAGERTHERAPEUTICS
Voyager Therapeutics
- Stock
Last Close
5.43
22/11 21:00
Market Cap
439.50M
Beta: -
Volume Today
359.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -14.62M - | -13.86M 5.21% | 1.69M 112.17% | 3.48M 106.40% | 3.66M 5.05% | 4.58M 25.08% | 4.33M 5.38% | 1.24M 71.26% | 389.50K 68.70% | |||
average payables | 1.25M - | 1.08M 13.50% | 581K 46.35% | 785K 35.11% | 1.03M 31.08% | 2.55M 148.20% | 2.35M 7.91% | 604K 74.32% | 1.57M 159.93% | 2.08M 32.80% | ||
average receivables | 205.50K - | 1.36M 560.34% | 1.21M 10.65% | 161.50K 86.68% | 9.59M 5,835.91% | 13.54M 41.24% | 4.43M 67.30% | 693.50K 84.34% | 42.55M 6,035.11% | |||
book value per share | 0.08 - | 40.34 51,556.69% | 5.37 86.68% | 5.00 6.90% | 1.45 71.04% | 2.77 91.38% | 4.16 49.92% | 2.52 39.28% | 1.54 39.02% | 5.30 244.59% | ||
capex per share | -0.20 - | -0.25 21.01% | -0.20 19.12% | -0.15 25.20% | -0.13 9.70% | -0.21 60.14% | -0.33 51.53% | -0.04 86.89% | -0.06 52.04% | -0.07 12.49% | ||
capex to depreciation | -16.24 - | -1.72 89.43% | -8.22 378.68% | -2.50 69.60% | -2.03 18.61% | -2.79 37.26% | -3.17 13.54% | -0.31 90.17% | -0.40 29.16% | -0.73 82.22% | ||
capex to operating cash flow | 0.25 - | -0.02 109.95% | 0.12 574.66% | 0.06 45.13% | 0.27 317.17% | -0.16 158.53% | 0.13 178.87% | 0.03 75.97% | 0.20 562.45% | -0.04 120.98% | ||
capex to revenue | -0.06 - | -0.35 495.17% | -0.39 11.18% | -0.57 43.70% | -0.07 86.92% | -0.07 4.39% | -0.04 39.16% | -0.06 41.60% | -0.01 78.61% | |||
cash per share | 0.48 - | 46.37 9,597.53% | 6.89 85.13% | 6.31 8.51% | 4.86 22.96% | 7.84 61.40% | 4.88 37.80% | 3.52 27.87% | 3.10 11.94% | 5.18 67.18% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | 131.83 - | |||||||||||
days sales outstanding | 8.65 - | 59.11 583.05% | 4.39 92.57% | 9.63 119.16% | 66.34 588.89% | 17.29 73.93% | 7.30 57.80% | 5.70 21.86% | 123.30 2,062.56% | |||
debt to assets | 19.64 - | 0.10 - | 0.18 88.96% | 0.23 25.22% | 0.15 36.32% | 0.06 60.19% | ||||||
debt to equity | -0.76 - | 0.34 - | 0.31 10.15% | 0.46 50.66% | 0.39 15.69% | 0.09 78.08% | ||||||
dividend yield | ||||||||||||
earnings yield | -0.06 - | -0.32 417.40% | -0.12 61.43% | -0.16 27.43% | -0.29 84.34% | -0.08 72.16% | 0.14 269.72% | -0.65 567.42% | -0.20 69.34% | 0.35 277.36% | ||
enterprise value | 2.79M - | 254.13M 9,001.92% | 60.48M 76.20% | 285.71M 372.42% | 413.41M 44.70% | 254.56M 38.42% | 448.91M 76.35% | 208.66M 53.52% | 28.83M 86.18% | 158.14M 448.56% | 327.66M 107.19% | |
enterprise value over ebitda | -17.92 - | -2.99 83.33% | -6.92 131.69% | -5.75 16.84% | -2.79 51.42% | -8.69 210.85% | 6.69 176.99% | -0.39 105.86% | -3.11 694.38% | 2.59 183.29% | ||
ev to operating cash flow | -21.32 - | 1.46 106.87% | -6.73 559.26% | -6.74 0.19% | -16.02 137.78% | 9.22 157.57% | -2.16 123.39% | -0.54 75.04% | -12.64 2,247.24% | 4.21 133.26% | ||
ev to sales | 3.49 - | 20.09 475.87% | 40.79 103.02% | 33.41 18.09% | 4.30 87.13% | 1.22 71.64% | 0.77 36.81% | 3.87 401.73% | 1.31 66.10% | |||
free cash flow per share | -1.01 - | 9.61 1,048.37% | -1.88 119.54% | -2.44 29.81% | -0.63 74.17% | 1.14 281.14% | -2.93 356.90% | -1.46 50.05% | -0.39 73.28% | 1.68 528.37% | ||
free cash flow yield | -0.06 - | 0.44 868.66% | -0.15 133.60% | -0.15 0.37% | -0.07 54.38% | 0.08 222.06% | -0.41 601.23% | -0.54 31.78% | -0.06 88.13% | 0.20 409.60% | ||
graham net net | -0.23 - | 28.55 12,777.27% | 4.87 82.93% | 4.46 8.37% | 0.87 80.49% | 1.16 33.09% | 2.25 93.81% | 0.93 58.46% | 0.51 45.86% | 4.02 695.99% | ||
graham number | 1.40 - | 80.16 5,642.51% | 13.86 82.71% | 17.23 24.33% | 9.47 45.02% | 8.42 11.08% | 9.62 14.20% | 9.98 3.72% | 6.47 35.13% | 18.82 190.80% | ||
income quality | 0.73 - | -1.39 290.56% | 1.06 175.94% | 0.87 17.90% | 0.18 79.26% | -1.12 720.34% | -2.63 135.82% | 0.75 128.56% | 0.27 64.15% | 0.59 118.45% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -61.01 - | -42.31 30.64% | 188.76 - | -28.37 115.03% | ||||||||
interest debt per share | 0.08 - | 0.04 51.30% | 0.95 - | 1.28 34.70% | 1.16 9.33% | 0.65 44.12% | 0.46 29.91% | |||||
inventory turnover | ||||||||||||
invested capital | -0.76 - | 0.34 - | 0.31 10.15% | 0.46 50.66% | 0.39 15.69% | 0.09 78.08% | ||||||
market cap | 261.16M - | 91.79M 64.85% | 322.35M 251.19% | 444.94M 38.03% | 301.42M 32.26% | 500.78M 66.14% | 265.50M 46.98% | 102.08M 61.55% | 233.98M 129.20% | 376.17M 60.77% | ||
net current asset value | -3.85M - | -1.99M 48.27% | 135.51M 6,909.60% | 125.14M 7.65% | 121.36M 3.02% | 31.90M 73.72% | 49.41M 54.90% | 90.50M 83.17% | 37.90M 58.13% | 24.16M 36.24% | 204.72M 747.26% | |
net debt to ebitda | 0.50 - | 1.55 211.65% | 0.89 42.61% | 0.44 50.55% | 0.51 17.24% | 1.00 95.14% | -1.82 281.47% | 1.00 154.63% | 1.49 49.91% | -0.38 125.72% | ||
net income per share | -1.11 - | -7.08 538.38% | -1.59 77.56% | -2.64 66.04% | -2.75 4.39% | -1.14 58.69% | 0.99 186.99% | -1.75 277.16% | -1.21 30.98% | 2.97 345.40% | ||
operating cash flow per share | -0.81 - | 9.85 1,316.48% | -1.68 117.04% | -2.29 36.33% | -0.50 78.35% | 1.36 373.62% | -2.60 292.13% | -1.42 45.45% | -0.33 77.05% | 1.75 636.08% | ||
payables turnover | 2.77 - | |||||||||||
receivables turnover | 42.18 - | 6.17 85.36% | 83.07 1,245.42% | 37.91 54.37% | 5.50 85.48% | 21.11 283.63% | 50.02 136.96% | 64.02 27.98% | 2.96 95.38% | |||
research and ddevelopement to revenue | 1.60 - | 2.97 86.07% | 6.14 106.76% | 8.52 38.67% | 1.15 86.54% | 0.64 44.59% | 1.97 210.32% | 1.49 24.68% | 0.35 76.38% | |||
return on tangible assets | -1.42 - | -0.13 90.89% | -0.21 63.96% | -0.38 80.75% | -0.50 30.13% | -0.12 76.92% | 0.14 222.03% | -0.34 342.51% | -0.29 14.50% | 0.38 229.35% | ||
revenue per share | 4.14 - | 0.56 86.41% | 0.38 32.72% | 0.24 37.16% | 2.91 1,123.86% | 4.61 58.48% | 0.99 78.45% | 1.07 7.37% | 5.61 425.97% | |||
roe | -14.20 - | -0.18 98.76% | -0.30 68.50% | -0.53 78.35% | -1.90 260.43% | -0.41 78.41% | 0.24 158.02% | -0.69 391.78% | -0.79 13.19% | 0.56 171.21% | ||
roic | -12.50 - | -0.12 99.06% | -0.30 159.21% | -0.52 72.23% | -1.96 273.54% | -0.29 85.27% | 0.11 139.77% | -0.37 424.56% | -0.48 29.77% | 0.44 191.31% | ||
sales general and administrative to revenue | 0.57 - | 0.93 63.25% | 1.95 108.69% | 4.44 127.85% | 0.35 92.16% | 0.20 41.25% | 1.00 386.85% | 0.76 23.92% | 0.14 81.08% | |||
shareholders equity per share | 0.08 - | 40.34 51,556.69% | 5.37 86.68% | 5.00 6.90% | 1.45 71.04% | 2.77 91.38% | 4.16 49.92% | 2.52 39.28% | 1.54 39.02% | 5.30 244.59% | ||
stock based compensation to revenue | 0.23 - | 0.44 91.01% | 0.91 105.41% | 2.06 126.22% | 0.15 92.73% | 0.09 41.75% | 0.30 246.82% | 0.23 24.53% | 0.04 80.47% | |||
tangible asset value | -3.83M - | 1.15M 129.98% | 169.07M 14,614.88% | 135.92M 19.61% | 134.05M 1.38% | 46.45M 65.35% | 99.51M 114.25% | 154.32M 55.08% | 95.06M 38.40% | 59.02M 37.91% | 236.32M 300.41% | |
tangible book value per share | 0.08 - | 40.34 51,556.69% | 5.37 86.68% | 5.00 6.90% | 1.45 71.04% | 2.77 91.38% | 4.16 49.92% | 2.52 39.28% | 1.54 39.02% | 5.30 244.59% | ||
working capital | -3.85M - | 5.88M 252.95% | 171.96M 2,822.55% | 164.98M 4.06% | 155.89M 5.51% | 130.81M 16.09% | 228.65M 74.80% | 171.00M 25.21% | 85.72M 49.87% | 51.91M 39.44% | 255.18M 391.59% |
All numbers in USD (except ratios and percentages)